.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Farmers Insurance
Medtronic
Express Scripts
Mallinckrodt
Julphar
Novartis
Johnson and Johnson
US Department of Justice
Fish and Richardson

Generated: June 24, 2017

DrugPatentWatch Database Preview

KLONOPIN Drug Profile

« Back to Dashboard

What is the patent landscape for Klonopin, and what generic Klonopin alternatives are available?

Klonopin is a drug marketed by Roche and is included in two NDAs.

The generic ingredient in KLONOPIN is clonazepam. There are ten drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the clonazepam profile page.

Summary for Tradename: KLONOPIN

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list3
Bulk Api Vendors: see list29
Clinical Trials: see list5
Patent Applications: see list4,342
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:KLONOPIN at DailyMed

Pharmacology for Tradename: KLONOPIN

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche
KLONOPIN
clonazepam
TABLET;ORAL017533-005Apr 9, 1997DISCNNoNo► Subscribe► Subscribe
Roche
KLONOPIN RAPIDLY DISINTEGRATING
clonazepam
TABLET, ORALLY DISINTEGRATING;ORAL020813-002Dec 23, 1997DISCNYesNo► Subscribe► Subscribe
Roche
KLONOPIN
clonazepam
TABLET;ORAL017533-002Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe
Roche
KLONOPIN RAPIDLY DISINTEGRATING
clonazepam
TABLET, ORALLY DISINTEGRATING;ORAL020813-003Dec 23, 1997DISCNYesNo► Subscribe► Subscribe
Roche
KLONOPIN
clonazepam
TABLET;ORAL017533-006Apr 9, 1997DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: KLONOPIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche
KLONOPIN
clonazepam
TABLET;ORAL017533-001Approved Prior to Jan 1, 19824,316,897► Subscribe
Roche
KLONOPIN
clonazepam
TABLET;ORAL017533-003Approved Prior to Jan 1, 19824,316,897► Subscribe
Roche
KLONOPIN
clonazepam
TABLET;ORAL017533-002Approved Prior to Jan 1, 19824,316,897► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Mallinckrodt
McKinsey
Cantor Fitzgerald
Argus Health
Julphar
Johnson and Johnson
Harvard Business School
Citi
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot